13F
← All fund report cards

VICTORY CAPITAL MANAGEMENT INC

13F equity value
$156.1B
Positions
2,410
Top 10 concentration
18.4%
Quarters / total new picks
32 / 2,359
13F equity value over time
$0M$89B$177B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +3.6% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 46.9% of quarters (excess t = 0.74, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
+1.2%
t-stat
0.74
Quarterly win rate
47%
Annualized excess
+2.1%
$1 → follow vs universe
$2.42 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.02720180630: follow 0.92220180930: follow 0.95020181231: follow 0.92320190331: follow 0.91120190630: follow 1.00920190930: follow 1.10320191231: follow 1.03320200331: follow 1.47320200630: follow 1.62020200930: follow 2.17920201231: follow 2.01220210331: follow 2.06320210630: follow 2.33320210930: follow 1.89820211231: follow 1.49220220331: follow 1.54220220630: follow 1.37720220930: follow 1.49120221231: follow 1.38920230331: follow 1.42920230630: follow 1.32020230930: follow 1.54120231231: follow 1.56720240331: follow 1.56220240630: follow 1.76520240930: follow 1.67820241231: follow 1.50120250331: follow 1.66920250630: follow 1.77520250930: follow 1.95020251231: follow 2.420 0.84 1.73 2.61 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 2410 · 2026 Q1

Ticker Value Weight QoQ
NVDA $5.7B
3.7%
TRIM
AAPL $4.7B
3.0%
TRIM
MSFT $4.0B
2.5%
TRIM
AMZN $3.5B
2.3%
TRIM
GOOGL $2.8B
1.8%
TRIM
LLY $1.7B
1.1%
TRIM
GOOG $1.7B
1.1%
TRIM
AVGO $1.6B
1.0%
TRIM
V $1.5B
0.9%
TRIM
META $1.5B
0.9%
ADD
BAC $1.2B
0.8%
TRIM
TFC $1.2B
0.8%
TRIM
LH $1.2B
0.8%
TRIM
CSCO $1.2B
0.8%
TRIM
BJ $1.1B
0.7%
TRIM
UPS $1.1B
0.7%
TRIM
NRG $1.0B
0.7%
TRIM
AMD $1.0B
0.7%
TRIM
SNPS $1.0B
0.7%
TRIM
MLM $964M
0.6%
TRIM

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.